Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
TNFL9 (human)

Overview
TNFL9 Cytokine that binds to TNFRSF9. Induces the proliferation of activated peripheral blood T-cells. May have a role in activation-induced cell death (AICD). May play a role in cognate interactions between T-cells and B-cells/macrophages. Belongs to the tumor necrosis factor family. Note: This description may include information from UniProtKB.
Protein type: Membrane protein, integral; Cytokine; Cell cycle regulation; Apoptosis
Cellular Component: extracellular space; plasma membrane; integral to membrane
Molecular Function: cytokine activity; tumor necrosis factor receptor binding; receptor binding
Biological Process: cell proliferation; positive regulation of interferon-gamma production; positive regulation of cytotoxic T cell differentiation; cell-cell signaling; apoptosis; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; myeloid dendritic cell differentiation; immune response; signal transduction; positive regulation of activated T cell proliferation
Reference #:  P41273 (UniProtKB)
Alt. Names/Synonyms: TNFSF9
Gene Symbols: TNFSF9
Molecular weight: 26,625 Da
Basal Isoelectric point: 6.52  Predict pI for various phosphorylation states
Select Structure to View Below

TNFL9

Protein Structure Not Found.


STRING  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  RCSB PDB  |  ENZYME  |  Phospho3D  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 Y3 _____MEYASDASLD
0 1 S111 DGPLSWYSDPGLAGV
0 1 S158-p RVVAGEGsGSVSLAL
0 1 S172-p LHLQPLRsAAGAAAL
0 1 T182-p GAAALALtVDLPPAS
0 1 S190-p VDLPPASsEARNSAF
  mouse

 
Y58-p ALPTDAAyPAVNVRD
S168-p NTTLNWHsQDGAGSS
H215 PTFTNTGHKVQGWVS
- gap
T240 DFDNLALTVELFPCS
M248 VELFPCSMENKLVDR
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.